Literature DB >> 35089558

Method for Production of Cysteine-Rich Proteins in Lactococcus lactis Expression System.

Susheel K Singh1,2, Vandana Singh3,4.   

Abstract

The Gram-positive bacterium Lactococcus lactis is an ideal expression host for the overproduction of heterologous proteins in a functional form. L. lactis has recently been identified as an efficient Gram-positive cell factory for the production of recombinant proteins and the safety of this production system has been confirmed in multiple clinical trials. Key desirable features of L. lactis include its generally recognized as safe (GRAS) status, long history of safe use in food production, probiotic properties, absence of endotoxins, capacity to secrete stable recombinant protein to the growth medium, the presence of few proteases, and a diverse selection of cloning and inducible expression vectors. Growth of lactococci is rapid, proceeds to high cell densities, and does not require aeration, which facilitates large-scale fermentation. We have previously described the production of several Plasmodium falciparum antigens with varying degrees of predicted structural complexities, those which are considered difficult-to-produce proteins by using L. lactis pH-dependent inducible promoter (P170). The purpose of this chapter is to provide a detailed protocol for the expression of difficult-to-produce proteins, mainly high cysteine-rich proteins, in the soluble form in L. lactis from cloning of the target gene to the determination of expression levels and purification.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Disulfide-rich protein; Fermenter; Lactococcus lactis; Malaria; Plasmodium falciparum; Protein secretion

Mesh:

Substances:

Year:  2022        PMID: 35089558     DOI: 10.1007/978-1-0716-1859-2_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis.

Authors:  Peter Ravn; José Arnau; Søren M Madsen; Astrid Vrang; Hans Israelsen
Journal:  Microbiology       Date:  2003-08       Impact factor: 2.777

2.  A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies.

Authors:  Susheel K Singh; Will Roeffen; Gorm Andersen; Teun Bousema; Michael Christiansen; Robert Sauerwein; Michael Theisen
Journal:  Vaccine       Date:  2015-02-26       Impact factor: 3.641

Review 3.  Lactococcus lactis-based vaccines from laboratory bench to human use: an overview.

Authors:  Mohammed Bahey-El-Din
Journal:  Vaccine       Date:  2011-12-07       Impact factor: 3.641

Review 4.  Production of disulfide-bonded proteins in Escherichia coli.

Authors:  Mehmet Berkmen
Journal:  Protein Expr Purif       Date:  2011-11-07       Impact factor: 1.650

Review 5.  Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion.

Authors:  E Morello; L G Bermúdez-Humarán; D Llull; V Solé; N Miraglio; P Langella; I Poquet
Journal:  J Mol Microbiol Biotechnol       Date:  2008

Review 6.  Heterologous protein production and delivery systems for Lactococcus lactis.

Authors:  Sébastien Nouaille; Luciana A Ribeiro; Anderson Miyoshi; Daniela Pontes; Yves Le Loir; Sergio Costa Oliveira; Philippe Langella; Vasco Azevedo
Journal:  Genet Mol Res       Date:  2003-03-31

7.  A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.

Authors:  Michael Theisen; Soe Soe; Katja Brunstedt; Frank Follmann; Lars Bredmose; Hans Israelsen; Søren M Madsen; Pierre Druilhe
Journal:  Vaccine       Date:  2004-03-12       Impact factor: 3.641

8.  A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages.

Authors:  Michael Theisen; Will Roeffen; Susheel K Singh; Gorm Andersen; Linda Amoah; Marga van de Vegte-Bolmer; Theo Arens; Régis Wendpayangde Tiendrebeogo; Sophie Jones; Teun Bousema; Bright Adu; Morten H Dziegiel; Michael Christiansen; Robert Sauerwein
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

9.  Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine.

Authors:  Susheel K Singh; Will Roeffen; Ulrik H Mistarz; Bishwanath Kumar Chourasia; Fen Yang; Kasper D Rand; Robert W Sauerwein; Michael Theisen
Journal:  Microb Cell Fact       Date:  2017-05-31       Impact factor: 5.328

10.  Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana.

Authors:  Festus K Acquah; Evans K Obboh; Kwame Asare; Johnson N Boampong; Samuel Victor Nuvor; Susheel K Singh; Michael Theisen; Kim C Williamson; Linda Eva Amoah
Journal:  Malar J       Date:  2017-08-01       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.